期刊文献+

CXCL10基因对乳腺癌细胞株MCF-7肿瘤相关基因表达的影响 被引量:4

The effects of transfection of CXCL10 gene into breast cancer cell line MCF-7 on expression of tumor related genes
原文传递
导出
摘要 目的构建CXCL10-pcDNA3.1(+)重组质粒及稳定转染乳腺癌细胞系MCF-7细胞株,探讨CXCL10对MCF-7细胞株肿瘤相关基因表达的影响。方法从1干扰素(IFN-1)刺激的人外周血单个核细胞中克隆CXCL10基因,构建CXCL10-pcDNA3.1(+)重组质粒,用CXCL10-pcDNA3.1(+)和对照质粒pcDNA3.1(+)分别以脂质体转染MCF-7细胞株,经G418筛选后获得稳定转染细胞株,以逆转录(RT)-PCR鉴定CXCL10基因表达,免疫印迹(WB)及ELISA鉴定CXCL10蛋白表达及分泌。以琼脂克隆形成实验分别计算实验组[转染CXCL10-pcDNA3.1(+)的MCF-7细胞株]、对照组[pcDNA3.1(+)的MCF-7细胞株]及未转染组(未转染的MCF-7细胞株)的细胞增殖活性;RT—PCR鉴定肿瘤相关基因基质金属蛋白酶9(MMP9)、血管内皮细胞生长因子(VEGF)及信号转导和转录激活因子3(STAT3)在各细胞株中的表达。结果重组质粒CXCL10-pcDNA3.1(+)及质粒pcDNA3.1(+)稳定转染MCF-7细胞株构建成功;克隆形成率在实验组、对照组及未转染组分别为78.2%、79.9%及87.8%,3组间比较差异无统计学意义(χ2=3.8,P〉0.05);实验组细胞能高效表达CXCL10mRNA,3组间比较差异有统计学意义(F=50.5,P〈0.01);ELISA结果显示细胞培养上清液中CXCL10的表达量3组间比较,差异有统计学意义(F=54.8,P〈0.01);MMP9基因转录水平在实验组、对照组及未转染组分别为0.067±0.003、0.103±0.007及0.085±0.026,均很低,且组间差异无统计学意义(F=4.2,P〉0.05);VEGF在实验组、对照组及未转染组灰度值分别为0.183±0.003、0.787±0.019及0.789±0.011,3组间比较差异有统计学意义(F=2232,P〈0.01);STAT3在实验组、对照组及未转染组灰度值分别为0.573±0.016、0.707±0.008及0.711±0.013,3组间比较差异有统计学意义(F=115,P〈0.01)。结论CXCL10能在MCF-7细胞株稳定表达,且CXCL10能抑制MCF-7细胞VEGF及STAT3表达,从而发挥抗肿瘤作用。 Objective To construct stable transfected MCF-7 cell line by recombinant plasmid CXCL10-pcDNA3.1 ( + ) and explore the effects of CXCL10 on expression of tumor related genes. Methods CXCL10 gene, cloned from treated PBMCs by IFN-5,,was used to construct recombinant plasmid CXCL10- peDNA3.1 ( + ). Recombinant plasmid CXCL10-pcDNA3.1 ( + ) and control plasmid pcDNA3.1 (+ ) were separately transfeeted into MCF-7 cells by lipifeetion-2000. The stable transfected cell lines were screened by G418. The transcription, expression and secretion of transfected CXCL10 gene was assayed by RT-PCR, Western blot and ELISA in turn. The cell growth activity of stable transfected cell lines was detected by soft agar cloning formation in experimental group [ transfected by CXCL10-pcDNA 3. 1 ( + ) ] , control group [transfected by pcDNA3.1 ( + )] and blank group (nothing transfected). Furthermore, the reverse transcriptions of three tumor related genes, included MMP9, VEGF and STAT3, were assayed by RT-PCR. Results The stable MCF-7 cell lines transfected by combined plasmid CXCL10-pcDNA3. 1 ( + ) and plasmid pcDNA3.1 ( + ) were constructed successfully. There was no significant difference in cell growth activity rate between the experimental group and the control group (χ2 = 3. 8, P 〉 0. 05, the rates of the 3 groups were 78.2% ,79.9% and 87.8% in turn). There was significant difference in CXCL10 mRNA expression level between the experimental group and the control group ( F = 50. 5, P 〈 0. 01 ). The ELISA result showed that CXCL10 had significant difference between the experimental group and the control group ( F = 54. 8,P 〈 0.01 ). MMP9, showed stable low expression level in the 3 groups simutaneously ( F = 4. 2, P〉0.05, the gray values of the 3 groups were seperately 0.067 ±0.003, 0. 103 ±0.007 and 0.085 ± 0. 026). Comparing with the control group, the experimental group showed significant lower expression level of VEGF (F=2 232,P 〈0. 01, the gray values of the 3 groups were 0. 183 ±0. 003, 0. 787 ±0. 019 and 0.789±0.011) and STAT3 (F=II5,P〈0.01, the gray values of the 3 groups were 0.573 ±0.016, 0. 707± 0. 008 and 0. 711 ± 0. 013 ). Conclusions CXCL10 can express stablely in MCF-7 cell lines, which resulted in down-regulation of expression of VEGF and STAT3 gene. CXCL10 played an important role in anti-tumor effect.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2009年第9期1059-1063,共5页 Chinese Journal of Laboratory Medicine
基金 浙江省医药卫生科技计划资助项目(2005A108)
关键词 乳腺肿瘤 细胞系 肿瘤 趋化因子CXCL10 基因表达 Breast neoplasms Cell line, tumor Chemopkine CXCL10 Gene expression
  • 相关文献

参考文献11

  • 1Goldberg-Bittman L, Neumark E, Sagi-Assif O, et al. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines. Immunol Lett, 2004,92:171-178.
  • 2Guo P, Fang Q, Tao HQ, et al. Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo. Cancer Res, 2003,63 : 4684-4691.
  • 3Di GH, Lu JS, Song CG, et al. Over expression of aromatase protein is highly related to MMPs levels in human breast carcinomas. J Exp Clin Cancer Res, 2005,24:601-607.
  • 4Bodnar R J, Yates CC, Wells A. IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circ Res, 2006,98:617-625.
  • 5Nagpal ML, Chen Y, Lin T. Effects of overexpression of CXCLIO (cytokine-responsive gene-2) on MA-10 mouse Leydig tumor cell steroidogenesis and proliferation. J Endocrinol, 2004, 183 : 585- 594.
  • 6Huang H, Xiang J. Synergistic effect of lymphotactin and interferon gamma-inducible protein-10 transgene expression in T- cell localization and adoptive T-cell therapy of tumors. Int J Cancer, 2004,109:817-825.
  • 7Datta D, Flaxenburg JA, Laxmanan S, et al. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB435 and MCF-7 cells: relevance for the development of human breast cancer. Cancer Res, 2006,66:9509-9515.
  • 8Shen Q, Zhang R, Bhat NR. MAP kinase regulation of IP10/ CXCL10 chemokine gene expression in microglial cells. Brain Res, 2006,1086:9-16.
  • 9Wincewicz A, Sulkowska M, Rutkowski R, et al. STAT1 and STA33 as intracellular regulators of vascular remodeling. Eur J Intern Med, 2007,18:267-271.
  • 10Chen Z, Han ZC. STAT3: a critical transcription activator in angiogenesis. Med Res Rev, 2008,28:185-200.

二级参考文献9

  • 1Darnell JEJr. Stats and gene regulation. Science, 1997, 277:1630-1635.
  • 2Watson C J, Miller WR. Elevated levels of members of the Stat family of transcriptional factors in breast carcinoma nuclear extracts. Br J Cancer, 1995, 71:840-844.
  • 3Bromberg JF, Wrzeszczynska MH, Devan G, et al. Stat3 as an oncogene. Cell, 1999, 98:295-303.
  • 4Grandis JR, Drenning SD, Zeng Q, et al. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci U S A, 2000, 97:4227-4232.
  • 5Mustafa Benekli, Zheng X, Kathleen A, et al. Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival.Blood, 2002, 99:252-257.
  • 6Caldenhoven E, van Dijk TB, Solari R, et al. STAT3β, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J Biol Chem, 1996,271 : 13221-13227.
  • 7Catlett-Falcone, Landowski, Oshiro, et al. Constitutively activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma ceils. Immunity, 1999,10 : 105-115.
  • 8马向涛,王杉,杜如昱,叶颖江,梁斌,王仲照,崔志荣.癌基因Stat3与结直肠癌临床病理特征的关系[J].中华普通外科杂志,2002,17(7):401-403. 被引量:9
  • 9程琳,王杉,叶颖江,张嘉庆,乔新民,杨德启,崔志荣.癌基因Stat3在人乳腺癌发生发展中的作用[J].中华普通外科杂志,2004,19(4):230-232. 被引量:16

共引文献1

同被引文献55

  • 1Lasagni L, Francalanci M, Annunziato F, et al . An alterna- spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC,and acts as functional receptor for platelet factor 4 [J]. J Exp Med,2003 , 197 (11) : 1537-1549.
  • 2Datta D, Flaxenburg JA, Laxmanan S, et al. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3- B in MDA-MB-435 and MCF 7 cells: relevance for the development of human breast cancer[J]. Cancer Res , 2006, 66 (19) : 9509-9518.
  • 3Herder C, Hauner H, Kempf K, et al. Constitutive and regulated expression and secretion of interferon gamma inducible protein 10(IP-10 /CXCL10)in human adipocytes[J]. Int J Obes ,2007,31(3) :403-410.
  • 4Luster AD, Leder P. IP-10, a-C-X-C-chemokine, elicits a potent thymus-dependent antitumor response in vivo[J]. J Exp Med ,1993,178(3) :1057-1065.
  • 5Huang H,Xiang J. Synergistic effect of lymphotactin and interferon gamma inducible protein-10 transgene expression in T-cell localization and adoptive T-cell therapy of tumors[J]. Int J Cancer ,2004,109(6) :817-825.
  • 6Lee L K, Roth C M. Antisense technology in molecular and cellular bioengineeing[J]. Curr Opin Biotechnol , 2003, 14 (5) 505-511.
  • 7Dufour JH,Dziejman M,liu MT, et al . IFN-gamma inducible protein 10(IP-10;CXCL10)-deficient mice reveal a role for IP- 10 in effector T cell generation and trafficking [J]. J Immunol, 2002,168(7) :3195-3204.
  • 8Bodnar RJ,Yates CC,Wells A. IP-IO blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of ealpain[J]. Circ Res , 2006,98(5), 617-625.
  • 9Proost P,Schutyser E,Menten P, et al. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties[J].Blood ,2001,98(13) .3554-3561.
  • 10Kolch W. Regulation of the expression of the VEGF/VPS and its reeeptors. role in tumor angiogenesis[J]. Breast Cancer Res Treat ,1995,36(2) :139-155.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部